◆英語タイトル:Intezyne Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10554
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Intezyne Inc (Intezyne) is a biotechnology company that develops product candidates for the treatment of various cancer tumors. The company offers anti-cancer agents and IVECT method to improve cancer therapy. It provides compounds that are cellular or molecularly targeted or have tumor-specific release mechanisms. Intezyne’s pipeline products include IT-139, IT-141 and IT-147. The company’s IT-141 is a formulation of SN-38 encapsulated using its nanoparticle drug delivery platform. It has active preclinical research programs for delivery of DNA and siRNA, molecularly targeted drugs and orally delivered IVECT therapeutics. Intezyne is headquartered in Tampa, Florida, the US.
Intezyne Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intezyne Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intezyne Inc, Medical Devices Deals, 2012 to YTD 2018 9
Intezyne Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Intezyne Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Intezyne Technologies Raises USD10 Million in Series A Preferred Financing 11
Partnerships 12
Exosome Diagnostics Enters into Agreement with Intezyne 12
Acquisition 13
Intezyne Technologies Acquires Niiki Pharma 13
Intezyne Inc – Key Competitors 15
Intezyne Inc – Key Employees 16
Intezyne Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Mar 15, 2018: Intezyne Taps Veteran Banker E. Russell McAllister as President and CEO 18
Product News 19
04/13/2018: Data Showing that IT-139 Triggers Immunogenic Cell Death (ICD) to Be Presented at AACR 2018 Annual Meeting 19
03/31/2017: Intezyne Technologies Announces Presentation on IT-139 at AACR Symposium 20
03/22/2018: Data on Cancer Resistance Pathway Inhibitor IT-139 to be Presented at AACR 2018 Annual Meeting 21
Product Approvals 22
Jun 20, 2017: Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer 22
Clinical Trials 23
Apr 16, 2018: Intezyne To Showcase Novel Cancer Resistance Pathway Inhibitor IT-139′S Potential In Gastric Cancer At ChinaBio Partnering Forum 2018 In Suzhou, PRC 23
Apr 10, 2018: Combination of Checkpoint Inhibitors and Intezyne’s Novel Cancer Resistance Pathway Inhibitor IT-139 Shows Enhanced Immune Efficacy 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Intezyne Inc, Pharmaceuticals & Healthcare, Key Facts 2
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intezyne Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intezyne Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Intezyne Inc, Medical Devices Deals, 2012 to YTD 2018 9
Intezyne Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Intezyne Technologies Raises USD10 Million in Series A Preferred Financing 11
Exosome Diagnostics Enters into Agreement with Intezyne 12
Intezyne Technologies Acquires Niiki Pharma 13
Intezyne Inc, Key Competitors 15
Intezyne Inc, Key Employees 16
List of Figures
Intezyne Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intezyne Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intezyne Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intezyne Inc, Medical Devices Deals, 2012 to YTD 2018 9